Brind.

Becton Dickinson is utilizing its Libertas wearable injector in a new trial, noting that the device is not subject to FDA 510(k) clearance.

2 reports, 2 independent Updated Jul 24

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Becton Dickinson is utilizing its Libertas wearable injector in a new trial, noting that the device is not subject to FDA 510(k) clearance.

Who's involved

What this event is mainly about

Becton Dickinson Food and Drug Administration

Keep exploring

The entities involved

Becton Dickinson
American multinational medical technology company

Nothing else this week.
Food and Drug Administration
government organization in Nonthaburi, Thailand
- Trump is expected to nominate Heidi Overton to lead the Food and Drug Administration.Mon 15:49
- In 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Mon 12:46

Coverage

Newest first; wire copies grouped

Jul 24Medical Device NetworkBD announces wearable injector trial for subcutaneous delivery of biologics Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas wearable injector for subcutaneous deliv
Jul 23PR NewswireBD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Com